Reference
Bosutinib Risk of interstitial lung disease WHO Pharmaceuticals Newsletter : 4, No. 3, 22 Aug 2023. Available from: URL: https://www.who.int/publications/i/item/who-pharmaceuticals-newsletter---no.-3--2023
Rights and permissions
About this article
Cite this article
Bosutinib-related risk of interstitial lung disease. Reactions Weekly 1973, 1 (2023). https://doi.org/10.1007/s40278-023-45729-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-45729-4